Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs3829012 | chr8:144664656 | C/T | 7.8E-5 | 490 | 30.77 | 32.23 | 33.58 | KM Plot |
PRAD | rs3836867 | chr5:154256584 | ATAT/A | 0 | 494 | 29.8 | 36.53 | 4.87 | KM Plot |
PRAD | rs3837737 | chr15:68017574 | C/CT | 5.98E-5 | 493 | 33.47 | 27.67 | 28.8 | KM Plot |
PRAD | rs3847829 | chr12:52840301 | G/A | 0.000134 | 491 | 29.2 | 36.33 | 22.93 | KM Plot |
PRAD | rs3858628 | chr12:52835426 | G/A | 0.00015 | 492 | 29.4 | 35.67 | 22.93 | KM Plot |
PRAD | rs3859419 | chr19:45493133 | T/G | 5.28E-5 | 484 | 45.2 | 30.77 | 30.8 | KM Plot |
PRAD | rs3861723 | chr13:113910926 | A/G | 2.04E-5 | 494 | 31.93 | 31.12 | 27.37 | KM Plot |
PRAD | rs3890988 | chr16:5006210 | G/A | 0.000148 | 484 | 31.27 | 29.95 | 26.37 | KM Plot |
PRAD | rs3897352 | chr1:16347854 | C/A | 2.36E-5 | 492 | 31.63 | 26.05 | 67.52 | KM Plot |
PRAD | rs3904666 | chr1:93704810 | G/A | 3.59E-6 | 494 | 31.37 | 26.8 | 18.97 | KM Plot |
PRAD | rs3948545 | chr5:171729453 | G/A | 1.29E-5 | 489 | 29.95 | 33.47 | 28.43 | KM Plot |
PRAD | rs3960393 | chr17:62983456 | C/T | 1.2E-8 | 482 | 30.8 | 31.62 | 19.63 | KM Plot |
PRAD | rs4069793 | chr9:72855898 | G/A | 1.73E-5 | 493 | 30.8 | 31.35 | 22.45 | KM Plot |
PRAD | rs4106950 | chr15:84791946 | T/G | 0.00015 | 488 | 31.25 | 29.97 | 44.3 | KM Plot |
PRAD | rs41270716 | chr1:167511595 | A/T | 0.00013 | 494 | 30.93 | 30.9 | 15.77 | KM Plot |